Souto Marcelo F O, Teixeira Antônio L, Russo Remo C, Penido Maria-Goretti M G, Silveira Kátia D, Teixeira Mauro M, Simões E Silva Ana C
Departamento de Pediatria, Universidade Federal de Minas Gerais, Belo Horizonte, MG, 30130-100, Brazil.
Pediatr Res. 2008 Dec;64(6):637-42. doi: 10.1203/PDR.0b013e318186ddb2.
The pathogenesis of idiopathic nephrotic syndrome (INS) remains unknown. Several findings suggest a role for the immune system. This study aimed to evaluate immune mediators in INS by measuring plasma and urinary levels of transforming growth factor beta1 (TGF-beta1), monocyte chemoattractant protein-1 (MCP-1/CCL2), regulated on activation normal T-cell expressed and secreted (RANTES/CCL5) and IL-8 (IL-8/CXCL8) in pediatric patients with INS and in age-matched healthy controls. Patients were divided according to their response to corticosteroids: steroid-sensitive (SS, n = 8), or steroid-resistant (SR, n = 24). Immune mediators were also compared in regard with disease activity (relapse and remission). Immune mediators were measured by ELISA. Plasma TGF-beta1 levels in SR patients were approximately 2.8-fold higher than control values (p < 0.05). Urinary IL-8/CXCL8 was 2.9-fold higher in INS patients in relapse (proteinuria >100 mg/m2/24 h) when compared with patients in remission (p < 0.05), and levels had a positive correlation with individual proteinuria values (p < 0.05). Urinary IL-8/CXCL8 was significantly higher in relapsed SR than in SS patients in remission. No changes in MCP-1/CCL2 and RANTES/CCL5 levels were detected. Our findings suggest that IL-8/CXCL8 and TGF-beta1 are involved in the pathogenesis of INS: IL-8/CXCL8 associated with local changes in glomerular permeability and TGF-beta1 could be related to worse response to corticosteroids.
特发性肾病综合征(INS)的发病机制尚不清楚。多项研究结果提示免疫系统发挥了作用。本研究旨在通过检测INS患儿及年龄匹配的健康对照者血浆和尿液中转化生长因子β1(TGF-β1)、单核细胞趋化蛋白-1(MCP-1/CCL2)、活化正常T细胞表达和分泌因子(RANTES/CCL5)及白细胞介素-8(IL-8/CXCL8)水平,评估INS中的免疫介质。根据患者对糖皮质激素的反应将其分为:激素敏感型(SS,n = 8)或激素抵抗型(SR,n = 24)。还比较了疾病活动期(复发和缓解)的免疫介质。采用酶联免疫吸附测定法(ELISA)检测免疫介质。SR患者血浆TGF-β1水平约比对照值高2.8倍(p < 0.05)。与缓解期患者相比,复发期(蛋白尿>100 mg/m2/24 h)的INS患者尿液IL-8/CXCL8高2.9倍(p < 0.05),且其水平与个体蛋白尿值呈正相关(p < 0.05)。复发的SR患者尿液IL-8/CXCL8显著高于缓解期的SS患者。未检测到MCP-1/CCL2和RANTES/CCL5水平的变化。我们的研究结果提示IL-8/CXCL8和TGF-β1参与了INS的发病机制:IL-8/CXCL8与肾小球通透性的局部改变有关,而TGF-β1可能与对糖皮质激素反应较差有关。